Kedar S Kirtane

23PUBLICATIONS
127CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 02, 2026
Emerging Treatments and Novel Modalities in Head and Neck Cancers.

|Apr 22, 2026
Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689.

|Apr 01, 2026
BASECAMP-1 screening study: a model for efficient enrolment in precision oncology clinical trials.

J Randolph Hecht, Julian R Molina, Kirstin Liechty

|Dec 10, 2025
Durable Complete Response of a Delta-Like Ligand 3 Expressing Head and Neck Neuroendocrine Carcinoma to Tarlatamab.

Kedar Kirtane, Sonam Puri, Christine H Chung

|Oct 21, 2025
Long-term Survival and Molecular Biomarker Evaluation of a Phase II Cetuximab and Nivolumab Clinical Trial in Recurrent/Metastatic Head and Neck Cancer.

Ritu Chaudhary, Graydon Moorhead, Robin Park

|Oct 04, 2025
Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical care.

Lisa M Gudenkauf, Danielle B Tometich, Aasha I Hoogland

Pageof 4

Frequent Collaborators

6 joint publications

Christine H Chung

6 joint publications

Heather S L Jim

6 joint publications

Brian D Gonzalez

5 joint publications

Nabil F Saba